Fli-1 directly activates miR-17-92 promoter and contributes to miR-17 and miR-20a expression in NN10#5 cells. by Samer Kayali (133888)

“…<p>A: NN10#5 cells have been cultured for two days in absence or presence of Dox used to induce Fli-1 knock-down before analysis. …”

Adding tsetse control to medical activities contributes to decreasing transmission of sleeping sickness in the Mandoul focus (Chad) by Mahamat Hissene Mahamat (4282306)

“…In the South of Chad, the Mandoul area is a persistent focus of Gambian sleeping sickness where around 100 HAT cases were still diagnosed and treated annually until 2013. …”

Twist1 and Snail1 protein levels after 100 μM RSV administration for 96 hs. by Chiara Cilibrasi (3636838)

Cytoplasmic and nuclear β catenin protein levels after 100 μM RSV administration for 96 hs. by Chiara Cilibrasi (3636838)

Hypercoordinate Silacycloalkanes: Step-by-Step Tuning of N→Si Interactions by Erica Brendler (1590736)

JNK inhibitor AS601245 decreased levels of Bim and CC3 proteins and reduced neuronal apoptosis and brain infarct volume in P7 rat after HI. by Deyuan Li (769599)

“…The infarct volume in the AS601245-treated brain was decreased by 58% compared with the DMSO controls (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0132998#pone.0132998.g004" target="_blank">Fig 4I</a>).…”

The effect of novel synthetic communities on plant shoot Pi content can be predicted by an NN. by Sur Herrera Paredes (674875)

“…The validation prediction error on NN is significantly smaller than LM (<i>p</i>-value = 5.25 × 10⁻¹⁰) and INT (<i>p</i>-value = 4.65 × 10⁻⁷). …”

Changes in mortality and DALYs per100,000 rates by cancer types from 1990 to 2019 in Iran; a) Mortality rate; b) DALYs per100000 rate. by Mitra Darbandi (17967619)

Localized schematic of ball valves with different openings (a) 25%; (b) 50%; (c) 75%; (d) 100%. by Weiqing Xu (1279959)

Distribution of hydrogen volume fraction at different openings (a) 25%; (b) 50%; (c) 75%; (d) 100%. by Weiqing Xu (1279959)

Expression of LMW tropomyosin in Type 2 diabetes. by Stuart A. Savill (3129060)

Tropomyosin isoform expression in normal controls and patients with Type 2 diabetes. by Stuart A. Savill (3129060)

Primer Sequences. by Stuart A. Savill (3129060)

Expression of HMW tropomyosin in Type 2 diabetes. by Stuart A. Savill (3129060)

TPM1 and TPM4 expression in response to TNFα. by Stuart A. Savill (3129060)

TPM1 protein expression in response to inflammatory cytokines. by Stuart A. Savill (3129060)

TPM1 and TPM4 expression in response to IL-1α. by Stuart A. Savill (3129060)

TPM1 and TPM4 expression in response to TNFα. by Stuart A. Savill (3129060)

TPM1 and TPM4 expression in response to glucose and insulin. by Stuart A. Savill (3129060)

TPM1 and TPM4 expression in response to IL-1α. by Stuart A. Savill (3129060)